Assessment

Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74,  Atlanta, Georgia 30333; ATTN:  PRA 0920-1050.

Adapting Clinical Guidelines for the Digital Age Meeting

The purpose of this Exit Survey for the “Adapting Clinical Guidelines for the Digital Age Meeting” that occurred Feb 5-9, 2018 is to gather your feedback on what worked well at this meeting and what could be improved in future meetings.

1. How did you participate in Adapting Clinical Guidelines for the Digital Age meeting?

___ In person only

___ Virtual only

___ In person and virtual

___ Did not participate

2. What days did you participate in the meeting? Check all that apply.

___ Monday

___ Tuesday

___ Wednesday

___ Thursday

___ Friday

3. What category (value stream) did you participate in the breakout sessions?

___ Informatics Framework for Guideline Translation

___ Dissemination Modalities and Communication Methods

___ Guideline Creation / Summarizing Evidence

___ Evaluation

___ Translation and Implementation Support

___ N/A – Virtual Participant

4. Please identify your stakeholder group.

Choose

___ Analytics

___ Consultant

___ EHR Vendor

___ Health Insurer

___ Centers for Disease Control and Prevention

___ Medical Research

___ Non-Profit Organization

___ Professional Society

___ University

___ Federal Government

___ Medical Center

___ State/ Local Health Department

___ Guideline Developer

___ Medical Association

___ Pharmaceutical

___ Standards Developer

___ Other

4a. If other, please specify your stakeholder group.

Your answer

5. How effective was this meeting in increasing your understanding of how each part of the clinical guideline process works?

Not At All Effective

1

2

3

4

5

Very Effective

6. How effective was your value stream/ breakout session in helping you understand the current state?

Not At All Effective

1

2

3

4

5

Very Effective

7. How effective was your value stream/ breakout session in helping you understand the ideal state?

Not At All Effective

1

2

3

4

5

Very Effective

8. How effective was your value stream/ breakout session in helping you understand the future state?

Not At All Effective

1

2

3

4

5

Very Effective

9. How effective was your breakout session facilitator in providing accurate reflections of the group’s input?

Not At All Effective

1

2

3

4

5

Very Effective

10. Was using the Kaizen method helpful in achieving outcomes of the value stream? Why or why not.

Your answer

11. Do you have a clear understanding of how the information gathered will be used to inform the post-Kaizen implementation of the future state?

Not at all Clear

1

2

3

4

5

Very Clear

12. Did the meeting meet your expectations?

Did not meet expectations

1

2

3

4

5

Met expectations

13. How effective was the meeting in improving the usability of clinical guidelines in patient care (e.g., through clinical decision support).

Not At All Effective

1

2

3

4

5

Very Effective

14. What do you think CDC’s role in adapting clinical guidelines for the digital age should be moving forward?

Your answer

15. What do you see as the main barriers to adapting clinical guidelines for the digital age going forward?

Your answer

16. What worked well during the meeting?

Your answer

17. What are some areas for improvement?

Your answer

18. Please provide any additional comments.

Your answer

Submit

Never submit passwords through Google Forms.